India's largest drugmaker, Ranbaxy Laboratories, today reported 48% dip in net profit (and minority interest) to Rs 101.3 crore for the quarter ended June 2005 as against Rs 195.8 crore for the same period last year.Consolidated sales of the company during the first quarter this fiscal grew 7% to Rs 1347.9 crore as compared to Rs 1258.0 crore in the year-ago period, company officials said.
